Related references
Note: Only part of the references are listed.Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment
F. P. Gullo et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort
Sheel Patel et al.
JOURNAL OF INFECTION (2013)
Fluconazole resistance in cryptococcal disease: emerging or intrinsic?
Jenny Wan Sai Cheong et al.
MEDICAL MYCOLOGY (2013)
Microbiological, Epidemiological, and Clinical Characteristics and Outcomes of Patients with Cryptococcosis in Taiwan, 1997-2010
Hsiang-Kuang Tseng et al.
PLOS ONE (2013)
Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole
A. Espinel-Ingroff et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Correlation of anti-fungal susceptibility with clinical outcomes in patients with cryptococcal meningitis
Chen-Hsiang Lee et al.
BMC INFECTIOUS DISEASES (2012)
In Vitro Susceptibilities of Yeast Species to Fluconazole and Voriconazole as Determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study
He Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Resistance of Asian Cryptococcus neoformans Serotype A Is Confined to Few Microsatellite Genotypes
Weihua Pan et al.
PLOS ONE (2012)
Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008
Nelesh P. Govender et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India
Anuradha Chowdhary et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease
Rebecca S. Shapiro et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2011)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Prevalence of the VNIc genotype of Cryptococcus neoformans in non-HIV-associated cryptococcosis in the Republic of Korea
Young Hwa Choi et al.
FEMS YEAST RESEARCH (2010)
Antifungal susceptibility, serotyping, and genotyping of clinical Cryptococcus neoformans isolates collected during 18 years in a single institution in Madrid, Spain
Jesus Guinea et al.
MEDICAL MYCOLOGY (2010)
Cryptococcus neoformans Overcomes Stress of Azole Drugs by Formation of Disomy in Specific Multiple Chromosomes
Edward Sionov et al.
PLOS PATHOGENS (2010)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China
Jianghan Chen et al.
EMERGING INFECTIOUS DISEASES (2008)
Serotype identification of Cryptococcus neoformans by multiplex PCR
S. Ito-Kuwa et al.
MYCOSES (2007)
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2006)
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis
E Dannaoui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan:: Surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003
PR Hsueh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates:: April 2000 to March 2002
B Sar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Share Paper
